Scientists develop simple blood test to track tumour evolution in cancer patients
02 May 2013Research sheds light on how tumours develop drug resistance
Research sheds light on how tumours develop drug resistance
Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman’s cancer is responding to treatment, according to a new study published in the New England Journal of Medicine.
Cambridge scientists have honed techniques originally developed to spot distant galaxies and used them to identify biomarkers that signal a cancer’s aggressiveness.
Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
Research could lead to more effective treatment.
Researchers have discovered how receptors for the female sex hormone oestrogen attach to a different part of the DNA in breast cancer patients who are more likely to relapse.
Patients who have benefited from life saving experimental cancer treatments will join world class researchers for a public open day.
Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.